Trump Orders FDA To Speed Up Review Of Psychedelic TherapeuticsPresident Donald Trump on Saturday signed an executive order directing the FDA to “expedite their review of certain psychedelics already designated as breakthrough therapy drugs” for conditions including depression and anxiety.“It’s for a lot of people, but it’s for our military in particular,” Trump said of the order. Drugs such as psilocybin and MDMA have been shown to have promising effects on veterans with post-traumatic stress disorder who have not responded to more conventional treatments. The directive, he said, “will clear away unnecessary bureaucratic hurdles, improve data-sharing among the FDA and the Department of Veterans Affairs, and facilitate fast rescheduling of any psychedelic drugs that become FDA-approved.”He held a press conference in the Oval Office surrounded by podcaster Joe Rogan, Health Secretary Robert F. Kennedy Jr. and Dr. Oz, Trump’s Medicare and Medicaid administrator, among others.“I got a call from a number of people including the great Joe Rogan, and he said we have to do something about this. And I looked into it,” Trump said.See All UpdatesClose